Navamedic sells chitin to Lytone Enterprise Inc. in Taiwan
Navamedic ASA has signed a letter of intent (LOI) with Lytone Enterprise Inc. in Taiwan for the sale of the first year's production from the company's planned new chitin factory at Senjahopen in Troms. The LOI between Navamedic's 100% owned subsidiary ChitiNor AS and Lytone Enterprise, Inc. in Taiwan covers the chitin production for one year from the start-up of the chitin factory and has a value of approximately NOK 7 million.
Chitin is the starting material for production of glucosamine, the active pharmaceutical ingredient in Navamedic's Glucomed product for osteoarthritis symptom treatment. Glucomed was recently approved for medicinal use in 20 European countries. Navamedic is currently building a network of marketing and distribution partners to prepare for a launch across Europe.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
List_of_Douglas-fir_diseases

Embryonic gene Nanog reverses aging in adult stem cells - The fountain of youth may reside in an embryonic stem cell gene
Illumina and Wellcome Trust Sanger Institute Announce Completed Genome for Endangered Tasmanian Devil - Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts

Building better brain organoids: A new framework for researchers - “Brain organoids are set to transform our understanding of human development, evolution and disease, and to provide insights we would otherwise not be able to gain”
Category:Burkholderiales
